|
| |
Articles
1-282 out of 282 article(s)
| Title |
Author |
Type |
Date |
Words |
| Reagents and contrast media. |
|
|
May 14, 2013 |
151 |
| Reagents and contrast media. |
|
|
May 8, 2013 |
123 |
| Reagents and contrast media. |
|
|
Apr 25, 2013 |
118 |
| Growth in Supply is Expected to Increase Faster than Demand and Lead to Prices Falling from Record Levels. |
|
|
Apr 24, 2013 |
919 |
| Growth in Supply is Expected to Increase Faster than Demand and Lead to Prices Falling from Record Levels. |
|
|
Apr 24, 2013 |
925 |
| Reagents and contrast media. |
|
|
Apr 23, 2013 |
116 |
| Pharmaceutical products . |
|
|
Apr 20, 2013 |
210 |
| FDA Approves Dotarem (gadoterate meglumine), first macrocyclic and ionic gadolinium-based contrast agent in USA. |
|
|
Apr 11, 2013 |
1085 |
| Supply, installation and commissioning of an mri and a contrast media injector. |
|
|
Apr 9, 2013 |
130 |
| FDA Approves Dotarem (gadoterate meglumine), First Macrocyclic and Ionic Gadolinium-based Contrast Agent in USA. |
|
|
Mar 27, 2013 |
833 |
| FDA Approves Dotarem (gadoterate meglumine), first macrocyclic and ionic gadolinium-based contrast agent in USA. |
|
|
Mar 21, 2013 |
1094 |
| Reagents and contrast media. |
|
|
Mar 21, 2013 |
137 |
| X-ray contrast media. |
|
|
Mar 12, 2013 |
127 |
| Reagents and contrast media. |
|
|
Feb 23, 2013 |
538 |
| Reagents and contrast media. |
|
|
Feb 19, 2013 |
111 |
| Reagents and contrast media. |
|
|
Feb 15, 2013 |
171 |
| Reagents and contrast media. |
|
|
Feb 14, 2013 |
487 |
| X-ray contrast media. |
|
|
Feb 7, 2013 |
130 |
| Provision of a ct contrast media injector including consumables and maintenance options - please use the following cardea link to express your interest in this tender project. |
|
|
Feb 6, 2013 |
127 |
| Reagents and contrast media. |
|
|
Feb 4, 2013 |
115 |
| Diagnostic Imaging Covers Communicating Contrast Agent Risk. |
|
|
Jan 29, 2013 |
533 |
| Reagents and contrast media. |
|
|
Jan 28, 2013 |
123 |
| Reagents and contrast media. |
|
|
Jan 25, 2013 |
101 |
| Reagents and contrast media. |
|
|
Jan 24, 2013 |
132 |
| Reagents and contrast media. |
|
|
Jan 22, 2013 |
120 |
| Reagents and contrast media. |
|
|
Jan 19, 2013 |
103 |
| Reagents and contrast media. |
|
|
Jan 19, 2013 |
109 |
| Contrast Media/Contrast Agents Market By Product (Iodinated, Gadolinium & Barium), By Technique (X-ray, CT, MRI, Cath Lab & Ultrasound) & By Application (Radiology, Interventional Radiology & Interventional Cardiology) - Global Trends & Forecast to 2017. |
|
|
Jan 14, 2013 |
4406 |
| Reagents and contrast media. |
|
|
Jan 12, 2013 |
168 |
| Global Contrast Media/Contrast Agents Market worth $8.6 Billion By 2017. |
|
|
Jan 8, 2013 |
901 |
| Global Contrast Media/Contrast Agents Market worth $8.6 Billion By 2017. |
|
|
Jan 8, 2013 |
905 |
| Reagents and contrast media. |
|
|
Jan 8, 2013 |
129 |
| Reagents and contrast media. |
|
|
Jan 8, 2013 |
205 |
| Research and Markets: Russian Federation Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others. |
|
Industry overview |
Dec 20, 2012 |
389 |
| US Contrast Agent and Radiopharmaceutical Market Saw a 15 Percent Decline between 2010 and 2012. |
|
|
Dec 20, 2012 |
629 |
| Research and Markets: France Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others. |
|
Industry overview |
Dec 19, 2012 |
393 |
| Research and Markets: Israel Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others. |
|
Industry overview |
Dec 19, 2012 |
392 |
| Research and Markets: Saudi Arabia Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others. |
|
Industry overview |
Dec 19, 2012 |
396 |
| Research and Markets: Austria Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others. |
|
Industry overview |
Dec 19, 2012 |
387 |
| Research and Markets: Australia Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others. |
|
Industry overview |
Dec 17, 2012 |
467 |
| Research and Markets: South and Central America Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others. |
|
Industry overview |
Dec 6, 2012 |
385 |
| Research and Markets: Italy Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others. |
|
Industry overview |
Dec 4, 2012 |
387 |
| Research and Markets: Brazil Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others. |
|
Industry overview |
Dec 4, 2012 |
388 |
| Research and Markets: Japan Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others. |
|
Industry overview |
Dec 3, 2012 |
382 |
| Research and Markets: Spain Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others. |
|
Industry overview |
Dec 3, 2012 |
387 |
| Research and Markets: Germany Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others. |
|
Industry overview |
Nov 30, 2012 |
390 |
| Research and Markets: Europe Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others. |
|
Industry overview |
Nov 30, 2012 |
388 |
| Research and Markets: Asia-Pacific Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others. |
|
Industry overview |
Nov 30, 2012 |
371 |
| Research and Markets: United States Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others. |
|
Industry overview |
Nov 29, 2012 |
394 |
| Research and Markets: Canada Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others. |
|
Industry overview |
Nov 29, 2012 |
393 |
| Research and Markets: Contrast Media Injectors Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018. |
|
Industry overview |
Nov 28, 2012 |
332 |
| Research and Markets: North America Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others. |
|
Industry overview |
Nov 15, 2012 |
386 |
| Radiopharmaceuticals and Contrast Media: Frost & Sullivan Predicts Market Growth in Europe. |
|
|
Nov 7, 2012 |
1060 |
| Radiopharmaceuticals and Contrast Media: Frost & Sullivan Predicts Market Growth in Europe. |
|
|
Nov 7, 2012 |
1062 |
| Experiences of using a single post-contrast CT scan of the urinary tract after triphasic contrast injection. |
Pretorius, Phil |
Case study |
Sep 1, 2012 |
444 |
| FDA Approves Labeling Changes for GE Healthcare's Optison[TM] (Perflutren Protein-Type A Microspheres Injectable Suspension, USP). |
|
|
Aug 21, 2012 |
1429 |
| CaRES Study Published in the Journal of the American Society of Echocardiography Further Demonstrates the Safety and Tolerability of Ultrasound Contrast Agent DEFINITY[R] in a Large and Diverse Patient Population. |
|
Clinical report |
Jul 2, 2012 |
1719 |
| Graphene-based MRI contrast agent 'more effective, less toxic'. |
|
|
Jun 10, 2012 |
308 |
| Experiences of using a single post-contrast CT scan of the chest after biphasic contrast injection. |
Pretorius, P.C. |
Report |
Jun 1, 2012 |
2133 |
| GE Healthcare Secures Additional Supply of Optison[TM] (Perflutren Protein-Type A Microspheres Injectable Suspension, USP). |
|
|
May 8, 2012 |
1137 |
| Global Imaging Agents Industry. |
|
Industry overview |
Apr 17, 2012 |
6920 |
| Focal neurological deficits due to a contrast enhancing lesion in a patient with systemic lupus erythematosus: case report and review of literature. |
Srikakulam, Sundeep; Askanase, Anca |
Clinical report |
Apr 1, 2012 |
2200 |
| MRI Contrast Agents Go Head-to-Head: Researchers Find Greater Morphologic Information and Lesion Enhancement with Bracco's MultiHance[R] (gadobenate dimeglumine) Injection, 529 mg/mL When Compared to Gadavist[TM] (gadobutrol injection). |
|
|
Mar 7, 2012 |
2084 |
| Molecular interactions between anticancer drugs and iodinated contrast media: an in vitro spectroscopic study. |
Ishii, Ryoichi; Mori, Hiromu; Matsumura, Kenji; Hongo, Norio; Kiyosue, Hiro; Matsumoto, Shunro; Yosh |
Report |
Jan 1, 2012 |
5248 |
| Physician Group Supports FDA Label Change for GE Healthcare Ultrasound Contrast Agent. |
|
|
Dec 13, 2011 |
540 |
| Nontoxic medical imaging agents form toxic DBPs. |
Potera, Carol |
Report |
Dec 1, 2011 |
1003 |
| Hospitals, Healthcare Providers to Benefit from a New Premier Agreement for Cardiac Ultrasound Contrast Media. |
|
|
Nov 21, 2011 |
221 |
| Integrative oncology for clinicians and cancer patients: part 2. |
Schachter, Michael B. |
Report |
Oct 1, 2011 |
6809 |
| Anatomical study of copulatory organ in male rabbit. |
Dadkhah, Mohammad Ali; Gilanpour, Hassan |
Report |
Sep 1, 2011 |
1454 |
| IT empowers contrast media injectors. |
Bolan, Cristen |
Report |
Jul 1, 2011 |
2010 |
| Human Health Care to Remain Largest Iodine Application Segment According To Merchant Research & Consulting, Ltd. |
|
|
Jun 29, 2011 |
319 |
| Renal functional MRI in mice evaluated with a dual bolus of intravascular and diffusible contrast agents. |
Pedersen, Michael; Topcu, Sukru Oguz; Sourbron, Steven; Nerregaard, Rikke |
Report |
Apr 1, 2011 |
2901 |
| CorMedix Announces Interim Analysis & Clinical Update for Phase II Study of CRMD001 (A Proprietary Formulation of Deferiprone). |
|
Clinical report |
Mar 31, 2011 |
1193 |
| U.S. FDA Approves Bayer's Gadavist(TM) (Gadobutrol) Injection for MRI of the Central Nervous System. |
|
|
Mar 15, 2011 |
1087 |
| Research and Markets: Radiology, Nuclear Medicine, Radiation Therapy, 2nd Edition (2011 Update). |
|
|
Mar 15, 2011 |
661 |
| U.S. FDA Approves Bayer's Gadavist(TM) (Gadobutrol) Injection for MRI of the Central Nervous System. |
|
|
Mar 14, 2011 |
1087 |
| MR-guided breast interventions: pearls and pitfalls. |
Ojeda-Fournier, Haydee; Mahoney, Mary C. |
Report |
Mar 1, 2011 |
2446 |
| Patient Preference For Omnipaque(TM) (Iohexol) Highlighted In First Head-To-Head Taste Test of Oral Contrast Agents. |
|
Clinical report |
Nov 10, 2010 |
1941 |
| MR contrast agents: applications in hepatobiliary imaging. |
Cher, Tan; Szklaruk, Janio |
Report |
Nov 1, 2010 |
4592 |
| Labeled Hepasphere behavior during venous drainage simulation at 1.5t. |
Jassar, Hassan; Langevin, Francois |
Report |
Nov 1, 2010 |
3104 |
| Research and Markets: European Contrast Media and Radiopharmaceutical Market. |
|
|
Oct 20, 2010 |
385 |
| Warning stricter on contrast agents. |
|
Brief article |
Oct 1, 2010 |
152 |
| FDA: new warnings required on use of gadolinium-based contrast agents. |
|
|
Sep 21, 2010 |
394 |
| Contrast-induced nephropathy in 2010. |
Katzberg, Richard W. |
Clinical report |
Sep 1, 2010 |
2789 |
| +PLUSPAK (polymer bottle) Packaging Receives GE's Distinguished ecomagination(SM) Approval. |
|
|
Aug 24, 2010 |
806 |
| Roskill Information Services: LCD Screens Continue to Drive Iodine Demand. |
|
|
Jul 13, 2010 |
4059 |
| Roskill Information Services: LCD Screens Continue to Drive Iodine Demand. |
|
|
Jul 13, 2010 |
4067 |
| GE Healthcare Medical Diagnostics Re-launches Optison(TM) Contrast Agent. |
|
|
Jul 12, 2010 |
1510 |
| Lantheus Medical Imaging, Inc. Presents Phase 4 Safety Data on DEFINITY[R] at American Society of Echocardiography Annual Meeting. |
|
|
Jun 14, 2010 |
1317 |
| Proceedings of the symposium on the management of established deep vein thrombosis involving the lower limb, held in Durban, march 2010. |
|
Clinical report |
Jun 1, 2010 |
2106 |
| Research and Markets: Contrast Media: A Market Snapshot of the Forecasted $7.9 Billion Industry. |
|
|
Feb 24, 2010 |
380 |
| Adding MRI Contrast Agent to Nanodiamond Improves Signal Intensity. |
|
|
Jan 16, 2010 |
684 |
| Case report: report of a rare case of juvenile recurrent parotitis and review of literature. |
Sujatha, S.; Namita, N.; Raghav, N.; Devaraju, D.; Shridevi, G. |
Case study |
Dec 1, 2009 |
2150 |
| Recognition and treatment of acute contrast reactions. |
Bush, William H., Jr.; Segal, Arthur J. |
Report |
Dec 1, 2009 |
3335 |
| Covidien Submits Label Change for Optimark[TM] Contrast Agent. |
|
|
Nov 9, 2009 |
950 |
| Incidence of contrast-induced nephropathy in intensive care patients undergoing computerised tomography and prevalence of risk factors. |
Rashid, A.H.; Brieva, J.L.; Stokes, B. |
Report |
Nov 1, 2009 |
4578 |
| Data Featuring Gadofosveset Trisodium, the First and Only MRA Blood Pool Agent Approved in The U.S., Presented At MRA-Club 09: The 21st Annual International Conference on Magnetic Resonance Angiography. |
|
Conference news |
Oct 8, 2009 |
970 |
| A review of iodine toxicity reports. |
|
Brief article |
Oct 1, 2009 |
177 |
| Contrast enhancement methods in sodium MR imaging: a new emerging technique. |
Sharma, Rakesh; Sharma, Avdhesh; Kwon, Soonjo; Booth, Ross |
Report |
Oct 1, 2009 |
8950 |
| Tx that won't melt in your hands. |
Franki, Richard |
Brief article |
Sep 15, 2009 |
212 |
| Anaphylactoid reaction to intravenous contrast in patient with systemic mastocytosis. |
Weingarten, T.N.; Volcheck, G.W.; Sprung, J. |
Case study |
Jul 1, 2009 |
2709 |
| New Study Demonstrates NanoScan's Novel Contrast Agent May Identify Heart Attack in Waiting. |
|
|
Jun 11, 2009 |
780 |
| A case of bilateral tuberculosis with a presenting symptom of massive haemoptysis/Masif hemoptizi ile bulgu veren bilateral tuberkuloz olgusu. |
Ozgen, Aylin; Celik, Pinar; Gulcu, Aytac; Konyar, Isin; Coskun, Aysin Sakar; Goktan, Cihan; Yorganci |
Report |
Jun 1, 2009 |
1818 |
| Cook Medical Launches Industry-First Pressure Injection Peripherally Inserted Catheter with Antibiotic Protection to Prevent Potentially Fatal Infections. |
|
|
May 11, 2009 |
757 |
| Lantheus Medical Imaging, Inc. Acquires U.S., Canadian and Australian Rights to MS-325 (Formerly Marketed as VASOVIST[R], Gadofosveset Trisodium, by Bayer Schering Pharma) from EPIX Pharmaceuticals. |
|
|
Apr 7, 2009 |
1198 |
| MRI in the era of nephrogenic systemic fibrosis: review, controversies and suggestions for risk reduction. |
Kuo, Phillip H.; Abu-Alfa, Ali; Bucala, Richard; Griffith, Jason; Carlson, Kacie; Girardi, Michael; |
Clinical report |
Apr 1, 2009 |
5787 |
| Detecting metastatic cancer lesions ... before it is too late! |
Goepp, Julius |
Report |
Mar 1, 2009 |
6012 |
| Imaging of appendicitis. |
Gajjar, Himal; Levy, Anthony |
Clinical report |
Dec 1, 2008 |
1941 |
| Study shows GE Healthcare's VisipaqueTM Associated with Lower Incidence of Contrast-Induced Nephropathy and Cardiovascular Events in Patients with Chronic Kidney Disease Compared to Iopromide. |
|
Clinical report |
Nov 21, 2008 |
1081 |
| Cook Medical Brings Power Injection Capability of Contrast Media to Spectrum(R) Antimicrobial Central Venous Catheter Line. |
|
|
Oct 28, 2008 |
475 |
| Hospitals, Healthcare Providers to Save with Premier Agreement for Cardiac Ultrasound Contrast Media. |
|
|
Oct 23, 2008 |
214 |
| Luna Innovations Receives Funding for Brain Cancer Diagnostic Agent Using Nanotechnology. |
|
|
Oct 7, 2008 |
878 |
| Myocardial blushing during coronary angiography due to high pressure applied by an inexperienced operator/Tecrubesiz bir operatorun koroner anjiyografi sirasinda uyguladigi yuksek basinca bagli miyokardiyal boyanma. |
Ozkan, Mustafa; Sag, Cemal; Yokusoglu, Mehmet; Uzun, Mehmet |
Case study |
Aug 1, 2008 |
289 |
| Late-Breaking Clinical Trial Results Reveal No Statistically Significant Difference between Isovue(R)-370 (Iopamidol Injection), or Visipaque(TM) 320 (Iodixanol) Injection in the Rate of CIN in High-Risk Patients Undergoing Computed Tomography. |
|
Clinical report |
Jul 31, 2008 |
1069 |
| Covidien Launches Contrast Delivery System with RFID. |
|
|
Jul 28, 2008 |
583 |
| Published Study Demonstrates Lower Serum Creatinine Levels after Contrast Media Administration with Iodixanol Than with Iopromide. |
|
|
Jul 16, 2008 |
692 |
| EPIX Pharmaceuticals Announces South Korean Approval of Vasovist(R); Novel Contrast Agent Now Approved for Marketing in 34 Countries. |
|
|
Jul 10, 2008 |
615 |
| Is MRI as safe as we think? |
Wahab, S.; Khan, R.A.; Ullah, E.; Wahab, A. |
Report |
Jul 1, 2008 |
2040 |
| CONTRAST Study: To What Extent Do High-Risk Patients Benefit From the Renal Tolerance of Iso-Osmolar X-Ray Contrast Media? |
|
|
Jun 6, 2008 |
640 |
| FDA Approves Covidien Contrast Delivery System with RFID. |
|
|
May 7, 2008 |
766 |
| Chronic kidney disease: CT or MRI? |
Morcos, Sameh K. |
Clinical report |
May 1, 2008 |
3799 |
| Luna Innovations Successfully Demonstrates MRI Contrast Agent. |
|
|
Apr 30, 2008 |
996 |
| Luna Innovations Plans Preclinical Studies and Collaboration with National Cancer Institute. |
|
|
Apr 9, 2008 |
894 |
| Iodixanol vs Iopromide Study Abstract Presented at American College of Cardiology 2008. |
|
Clinical report |
Apr 1, 2008 |
497 |
| Cheap drug protects kidneys from contrast agent harm. |
|
Brief article |
Apr 1, 2008 |
168 |
| Review of common and uncommon contrast media reactions. |
Hesley, Gina; Hartman, Robert |
|
Apr 1, 2008 |
2226 |
| FDA gets flak for contrast warning. |
Dixon, Bruce K. |
|
Jan 1, 2008 |
1842 |
| Management of hypopharyngeal and esophageal perforations in children: three case reports and a review of the literature. |
Baum, Eric D.; Elden, Lisa M.; Handler, Steven D.; Tom, Lawrence W.C. |
Clinical report |
Jan 1, 2008 |
2048 |
| Assessing renal function before administering contrast media. |
Dallessio, Kathleen M. |
|
Dec 1, 2007 |
1098 |
| Luna Works with the National Institutes of Health Exploring New Diagnostics for Heart Attack Prevention. |
|
|
Nov 29, 2007 |
1062 |
| Insight Agents Launches Generic Contrast Media and Attractive Business Model in Europe. |
|
|
Nov 23, 2007 |
748 |
| HealthTrust Purchasing Group and Bracco Diagnostics Inc. Sign Three-Year Agreement for X-Ray Contrast Media. |
|
|
Nov 9, 2007 |
651 |
| ACRIN TRIAL EVALUATES IMAGING FOR STAGING CERVICAL CANCER. |
|
|
Nov 1, 2007 |
438 |
| Revised labels for contrast agents due to deaths. |
|
Brief article |
Oct 22, 2007 |
201 |
| FDA Clears Hand-Held Disposable Injector for Angiographic Imaging. |
|
|
Oct 10, 2007 |
384 |
| Ultrasound drugs face black-box warning. |
|
|
Oct 8, 2007 |
385 |
| FDA, Bayer issue letter to doctors about MRI agents. |
|
Brief article |
Oct 8, 2007 |
210 |
| Bracco Diagnostics Inc. and HealthTrust Purchasing Group Sign a Three-Year Agreement for Contrast Media. |
|
|
Oct 5, 2007 |
836 |
| Frost & Sullivan Lauds the Outstanding Product Quality of Guerbet's Flagship X-ray Contrast Agent. |
|
Company overview |
Sep 20, 2007 |
807 |
| Docs in dark on contrast nephropathy. |
Lowry, Fran |
|
Sep 15, 2007 |
373 |
| Reactions to new contrast agents rare in children. |
|
Brief article |
Aug 1, 2007 |
205 |
| FDA requests warning for MR contrast agents. |
|
Brief article |
Aug 1, 2007 |
184 |
| Intratracheal ectopic thyroid: case report and review. |
Karakullukcu, Baris; Guvenc, M. Gtiven; Cansiz, Harun; Oktem, Fatih; Oz, Buge |
Clinical report |
Jul 1, 2007 |
2109 |
| FDA requests boxed warning for MRI contrast agents. |
|
|
Jun 4, 2007 |
355 |
| Panel considers contrast safety measures. |
Faguy, Katie |
|
Jun 1, 2007 |
1117 |
| Contrast media and seafood allergy link is fishy. |
Finn, Robert |
Survey |
May 15, 2007 |
754 |
| MRI contrast agents tied to rare skin disease in kidney patients. |
|
|
Mar 26, 2007 |
465 |
| Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients. |
Pucci, Laura; Triscornia, Stefano; Lucchesi, Daniela; Fotino, Carmen; Pellegrini, Giovanni; Pardini, |
|
Mar 1, 2007 |
7330 |
| MR contrast agent implicated in serious skin condition. |
|
|
Feb 1, 2007 |
422 |
| Milk appears promising as oral contrast agent. |
Wendling, Patrice |
Clinical report |
Feb 1, 2007 |
599 |
| MR contrast tied to skin syndrome. |
Dixon, Bruce K. |
|
Jan 15, 2007 |
1206 |
| Hemofiltration averts contrast nephropathy. |
Jancin, Bruce |
|
Jul 1, 2006 |
540 |
| Myelography in the pigeon (Columba livia). |
Naeini, Aboutorab Tabatabaei; Dadras, Habibollah; Naeini, Bahram Ataei |
|
Mar 1, 2006 |
1814 |
| Imaging agent may cause cardiopulmonary failure. |
Moon, Mary Ann |
|
Jan 1, 2006 |
294 |
| MR contrast agents. |
Kalva, Sanjeeva P.; Blake, Michael A.; Sahani, Dushyant V. |
|
Jan 1, 2006 |
3755 |
| Simple cystatin C--based prediction equations for glomerular filtration rate compared with the Modification of Diet in Renal Disease prediction equation for adults and the Schwartz and the Counahan--Barratt prediction equations for children. |
Grubb, Anders; Nyman, Ulf; Bjork, Jonas; Lindstrom, Veronica; Rippe, Bengt; Sterner, Gunnar; Christe |
Report |
Aug 1, 2005 |
9249 |
| Contrast-medium-induced nephrotoxicity. |
Thomsen, Henrik S.; Morcos, Sameh K. |
|
Jan 1, 2005 |
4958 |
| Acetylcysteine helps prevent contrast nephropathy; adjunct to hydration. |
Wachter, Kerri |
Brief Article |
Oct 1, 2003 |
261 |
| Iodinated contrast media interfere with gel barrier formation in plasma and serum separator tubes. |
Spiritus, Tom; Zaman, Zahur; Desmet, Walter |
|
Jul 1, 2003 |
1689 |
| Contrast medium nephropathy. (Clinical Capsules). |
Ann Moon, Mary |
Brief Article |
Apr 1, 2003 |
144 |
| Two drugs to prevent contrast nephropathy found unsuitable. (Case-Control Data). |
Moon, Mary Ann |
Brief Article |
Feb 1, 2003 |
204 |
| Feedback cuts contrast agent use. (Volume Cut by Nearly 60%). |
Moon, Mary Ann |
|
Feb 1, 2003 |
366 |
| Contrast nephropathy. (Clinical Capsules). |
Moon, Mary Ann |
Brief Article |
Mar 15, 2002 |
194 |
| North American Scientific's Apomate for use in cardiac transplant rejection diagnosis receives orphan drug designation. |
|
Brief Article |
Dec 29, 2000 |
107 |
| Enhancement along the facial nerve on MRI. |
Valvassori, Galdino |
|
Oct 1, 2000 |
245 |
| ACIST GETS FDA CLEARANCE FOR CONTRAST MANAGEMENT SYSTEM. |
|
Brief Article |
Jul 1, 2000 |
690 |
| Advanced Magnetics, Inc. Completes Phase III Lymph Node Study of Combidex Magnetic Resonance Imaging Contrast Agent. |
|
|
Oct 23, 1998 |
313 |
| U.S. Patent Office Issues Final Rejection of Key Nycomed Patent. |
|
Article |
Aug 25, 1998 |
459 |
| REPEAT/Diatide Submits Second New Drug Application to the FDA. |
|
Article |
Jun 16, 1998 |
822 |
| Molecular Biosystems and Mallinckrodt Launch OPTISON in Europe; Product Shipped Within 24 Hours of Approval. |
|
|
May 27, 1998 |
456 |
| Molecular Biosystems Reports Initial Sales of OPTISON, Q4 and Fiscal Year-End Financial Results. |
|
|
May 13, 1998 |
889 |
| GastroMARK MRI Contrast Agent Now Part of Mallinckrodt Agreement With Premier |
|
|
May 12, 1998 |
395 |
| Kaire Holdings Incorporated's Potomac Chemicals Sets April 23, 1998 for Its Seventh Anniversary Meeting of Its Mainland China's 300,000 Consumer Distributors. |
|
|
Apr 13, 1998 |
184 |
| Advanced Magnetics, Inc. Announces South Korean Approval of Feridex I.V. Liver Contrast Agent |
|
|
Apr 6, 1998 |
352 |
| OPTISON Recommended for European Approval; New Ultrasound Imaging Agent Will Aid in the Detection of Cardiac Disease. |
|
|
Jan 29, 1998 |
677 |
| OPTISON Off to a Solid Start in Ultrasound Imaging Market. |
|
|
Jan 28, 1998 |
733 |
| Molecular Biosystems Reports Third Quarter Financial Results. |
|
|
Jan 21, 1998 |
1457 |
| Advanced Magnetics, Inc. Reports First Fiscal Quarter Results |
|
|
Jan 21, 1998 |
678 |
| Diatide's Acutect Scheduled For FDA Panel Review. |
|
|
Jan 9, 1998 |
847 |
| New Ultrasound Imaging Agent, Optison, Cleared by FDA; First of the New Generation Ultrasound Agents. |
|
|
Jan 5, 1998 |
718 |
| Immunomedics' CEA-Scan(R) Product Can Affect Surgical Management of Colorectal Cancer |
|
|
Nov 20, 1997 |
1093 |
| EPIX Medical, Inc. Announces Completion of Follow-On Stock Offering; Underwriters Exercise Over-allotment Option |
|
|
Nov 19, 1997 |
306 |
| BancAmerica Robertson Stephens Reissues EPIX Medical Price Target of $19 |
|
|
Nov 18, 1997 |
480 |
| Advanced Magnetics, Inc. Authorizes Repurchase of Stock |
|
|
Nov 10, 1997 |
241 |
| SONUS Echocardiographic Contrast Agents Subject of Four Presentations at the AHA Scientific Sessions |
|
|
Nov 6, 1997 |
740 |
| Diatide's Lung Cancer Imaging Product is Presented at the American College of Chest Physicians Annual Meeting. |
|
|
Oct 29, 1997 |
726 |
| Syncor Reports Third Consecutive Quarter of Double Digit Growth in Net Income From Continuing Operations. |
|
|
Oct 24, 1997 |
997 |
| Molecular Biosystems Reports Second-Quarter Financial Results. |
|
|
Oct 23, 1997 |
777 |
| EPIX Medical Reports Results For Third Quarter |
|
|
Oct 21, 1997 |
977 |
| Palatin Submits IND With The FDA For Kit-Packaged Radioimaging Diagnostic System; IND Filed With FDA. |
|
|
Oct 15, 1997 |
381 |
| SONUS Notified That Medical Imaging Drug Advisory Committee is not Required For FDA Review of EchoGen(R) |
|
|
Oct 2, 1997 |
582 |
| U.S. Patent Office to Reconsider Validity of Nycomed Contrast Agent Patent. |
|
|
Sep 25, 1997 |
511 |
| Alliance Pharmaceutical Corp. Announces Agreement With Schering AG, Germany, For Ultrasound Contrast Agent. |
|
|
Sep 24, 1997 |
605 |
| Nycomed Inc. and UHC Announce New Three-Year Agreement |
|
|
Sep 11, 1997 |
535 |
| New Diagnostic Imaging Technology Promises To Change How Lung Cancer is Diagnosed and Treated; By Better Staging Progress of Disease, ADAC Laboratories' MCD May Reduce Unnecessary Lung Cancer Surgery. |
|
|
Aug 24, 1997 |
834 |
| SONUS Pharmaceuticals Initiates Phase 3 EchoGen(R) Trial in Contrast-Enhanced Stress Echocardiography |
|
|
Aug 19, 1997 |
816 |
| Molecular Biosystems Reports First Quarter Financial Results. |
|
|
Aug 7, 1997 |
905 |
| EPIX Medical Reports Results for Second Quarter |
|
|
Aug 7, 1997 |
787 |
| Measurement of serum iohexol by determination of iodine with inductively coupled plasma-atomic emission spectroscopy. |
Braselton, W. Emmett; Stuart, Kirk J.; Kruger, John M. |
|
Aug 1, 1997 |
5518 |
| Alliance Pharmaceutical Corp. to Collaborate With Schering AG On Ultrasound Contrast Agent |
|
|
Jul 21, 1997 |
440 |
| EPIX Medical Receives $2,000,000 Milestone Payment |
|
|
Jul 17, 1997 |
560 |
| Advanced Magnetics, Inc. Elects Harvard Professor Joseph B. Lassiter, Ph.D. To Board Of Directors |
|
|
Jul 2, 1997 |
303 |
| Brand Name Chosen for Proposed Ultrasound Imaging Agent FS069 |
|
|
May 7, 1997 |
396 |
| Mallinckrodt, Medi-Physics Reach Agreement on Myoview(TM) Heart Imaging Agent |
|
|
May 5, 1997 |
409 |
| Advanced Magnetics, Inc. Reports Results For The Second Fiscal Quarter And Six Months Ended March 31, 1997 |
|
|
Apr 15, 1997 |
637 |
| Pharmacyclics Revises GADOLITE Timetable Based on FDA Meeting |
|
|
Mar 26, 1997 |
697 |
| SONUS Pharmaceuticals' EchoGen(R) Enhanced Echocardiography Compares Favorably to MRI in Diagnosing Severely Depressed Cardiac Function |
|
|
Mar 20, 1997 |
823 |
| SONUS Pharmaceuticals' Ultrasound Contrast Agents Are Subject of Seven American College of Cardiology Presentations |
|
|
Mar 17, 1997 |
1103 |
| High-Tech Heart Scan Overcomes Challenges of Detecting #1 Killer In Women: Heart Disease |
|
|
Feb 13, 1997 |
922 |
| EPIX Medical Announces Initial Public Offering of Common Stock |
|
|
Jan 30, 1997 |
244 |
| SONUS Pharmaceuticals Files for Approval of EchoGen(R) Emulsion in The European Union |
|
|
Jan 8, 1997 |
704 |
| Diatide Completes Phase 3 Clinical Trials Of P280 for Detecting Deep Vein Thrombosis |
|
|
Jan 6, 1997 |
546 |
| Molecular Biosystems, Mallinckrodt Expand Partnership for Marketing of FS069 |
|
|
Dec 16, 1996 |
566 |
| SONUS Pharmaceuticals Announces First Use of EchoGen(R) Emulsion in Prostate Cancer Study |
|
|
Dec 3, 1996 |
671 |
| METASYN Becomes EPIX Medical |
|
|
Nov 18, 1996 |
195 |
| SONUS Pharmaceuticals, Inc. Announces Profitable Third Quarter Results |
|
|
Oct 23, 1996 |
1103 |
| Molecular Biosystems, Mallinckrodt File For PMA for Next Generation Ultrasound Imaging Agent, FS069 |
|
|
Oct 18, 1996 |
795 |
| Advanced Magnetics, Inc. Announces Receipt of $5 Million Milestone Payment for U.S. Introduction of Feridex I.V.(TM) Contrast Agent |
|
|
Oct 15, 1996 |
341 |
| SONUS Pharmaceuticals and Abbott Laboratories Expand Alliance for EchoGen(R) To International Territories |
|
|
Oct 7, 1996 |
880 |
| Phase 3 Clinical Findings Submitted on use of ALBUNEX(R) for Fallopian Tube Patency |
|
|
Sep 16, 1996 |
604 |
| E-Z-EM Inc. introduces contrast agent for new "see-through" small bowel radiographic study; Entero Vu(TM) provides detailed images not possible with conventional small bowel x-ray examination. |
|
|
Sep 5, 1996 |
419 |
| SONUS Pharmaceuticals Regains European Marketing Rights for EchoGen(R) Following Guerbet's Election Not to Exercise License Option |
|
|
Aug 28, 1996 |
448 |
| SONUS Pharmaceuticals Announces $3,000,000 Daiichi Milestone Payment for Successful Demonstration of Myocardial Perfusion in EchoGen(R) Trial |
|
|
Aug 28, 1996 |
574 |
| SONUS Pharmaceuticals, Inc. Adopts Shareholder Rights Plan |
|
|
Aug 21, 1996 |
508 |
| CPAC Signs Contract with Nation's Largest X-ray Distribution Group |
|
|
Aug 7, 1996 |
336 |
| Molecular Biosystems Announces Favorable Phase 3 Clinical Trial Results of its Ultrasound Contrast Agent, FS069. |
|
|
Jul 17, 1996 |
1160 |
| MALLINCKRODT INTRODUCES OPTIRAY(R) IN ULTRAJECT(R) SYRINGES IN JAPAN, WORLD'S SECOND LARGEST MEDICAL IMAGING MARKET |
|
|
Jul 1, 1996 |
334 |
| IMMUNOMEDICS COMPLETES $10 MILLION FINANCING |
|
|
Jun 28, 1996 |
419 |
| METASYN COMPLETES FOURTH ROUND FINANCING |
|
|
Jun 13, 1996 |
255 |
| INVESTIGATORS PRESENT FAVORABLE RESULTS OF SONUS PHARMACEUTICALS U.S. PHASE 3 CARDIOLOGY TRIAL OF ECHOGEN(R) EMULSION |
|
|
Jun 10, 1996 |
1138 |
| Landmark agreement in radiographic contrast media market announced by Bracco Diagnostics and AmeriNet. |
|
|
Jun 3, 1996 |
427 |
| Molecular Biosystems completes public offering of 3.6 MM shares of common stock. |
|
|
May 24, 1996 |
164 |
| SONUS PHARMACEUTICALS AND ABBOTT LABORATORIES SIGN AGREEMENT FOR ECHOGEN(R) EMULSION IN THE U.S. |
|
|
May 15, 1996 |
573 |
| /C O R R E C T I O N -- SONUS PHARMACEUTICALS, INC./(Correction Notice) |
|
Correction Notice |
May 15, 1996 |
687 |
| PHARMACYCLICS REPORTS THIRD-QUARTER RESULTS |
|
|
May 14, 1996 |
996 |
| ADVANCED MAGNETICS, INC. AUTHORIZES REPURCHASE OF STOCK |
|
|
May 8, 1996 |
258 |
| ADVANCED MAGNETICS, INC. RECEIVES APPROVABLE LETTER FROM FDA FOR SECOND CONTRAST AGENT, GASTROMARK |
|
|
May 7, 1996 |
389 |
| /C O R R E C T I O N -- SONUS PHARMACEUTICALS, INC./(Correction Notice) |
|
Correction Notice |
Apr 25, 1996 |
996 |
| SONUS PHARMACEUTICALS, INC. ANNOUNCES FIRST QUARTER RESULTS |
|
|
Apr 24, 1996 |
945 |
| E-Z-EM Inc. announces third quarter fiscal 1996 results; Earnings from continuing operations increased 87% from first nine months of fiscal 1995. |
|
|
Apr 16, 1996 |
818 |
| ADVANCED MAGNETICS WITHDRAWS PUBLIC OFFERING |
|
|
Apr 10, 1996 |
245 |
| IMMUNOMEDICS RECEIVES FDA APPROVABLE LETTER FOR CEA-SCAN |
|
|
Apr 10, 1996 |
400 |
| SONUS PHARMACEUTICALS RETAINS HILL & KNOWLTON |
|
|
Apr 9, 1996 |
304 |
| Alliance Pharmaceutical Corp. announces public offering. |
|
|
Apr 2, 1996 |
181 |
| BRISTOL-MYERS SQUIBB, OXFORD UNIVERSITY AND AMERSHAM SIGN AGREEMENT FOR NEW ALZHEIMER'S DIAGNOSTIC AGENT |
|
|
Apr 1, 1996 |
759 |
| INVESTIGATORS PRESENT FIRST RESULTS FROM SONUS PHARMACEUTICALS U.S. PHASE 2 MYOCARDIAL PERFUSION TRIAL OF ECHOGEN(R) EMULSION |
|
|
Mar 26, 1996 |
921 |
| INVESTIGATORS PRESENT RESULTS OF SONUS PHARMACEUTICALS U.S. PHASE 3 RADIOLOGY TRIAL OF ECHOGEN(R) EMULSION |
|
|
Mar 18, 1996 |
1155 |
| SONUS PHARMACEUTICALS COMPLETES FINAL PHASE 3 TRIAL PRIOR TO NDA SUBMISSION FOR ECHOGEN(R) EMULSION |
|
|
Mar 14, 1996 |
632 |
| Smart molecules may enhance images. |
Lipkin, Richard |
|
Feb 17, 1996 |
498 |
| E-Z-EM, introduces new contrast medium for abdominal/pelvic CT studies; Product offers benefits and safety not available with iodinated contrast agents. |
|
|
Feb 15, 1996 |
325 |
| SONUS PHARMACEUTICALS, INC. ANNOUNCES YEAR END AND FOURTH QUARTER RESULTS |
|
|
Feb 15, 1996 |
1107 |
| Interactive Medical Technologies Ltd. finalizes agreement with E-Z-EM Inc. |
|
|
Feb 7, 1996 |
345 |
| E-Z-EM declares stock dividend. |
|
|
Jan 26, 1996 |
200 |
| Advanced Magnetics reports first fiscal quarter results. |
|
|
Jan 17, 1996 |
462 |
| SONUS PHARMACEUTICALS, INC. TO PRESENT AT HAMBRECHT & QUIST |
|
|
Jan 9, 1996 |
568 |
| NJHA AND BRACCO DIAGNOSTICS SIGN LONG-RANGE CONTRACT |
|
|
Dec 6, 1995 |
267 |
| NJHA/Bracco Diagnostics sign long-range contract. |
|
|
Dec 5, 1995 |
240 |
| E-Z-EM Inc. completes divestiture of subsidiary to U.S. Surgical. |
|
|
Nov 27, 1995 |
264 |
| Alliance Pharmaceutical Corp. announces first-quarter financial results. |
|
|
Nov 13, 1995 |
438 |
| Molecular Biosystems reports second- quarter financial results. |
|
|
Nov 9, 1995 |
743 |
| Immunomedics and FDA planning Medical Imaging Drugs Advisory Committee hearing for CEA-Scan. |
|
|
Nov 1, 1995 |
358 |
| SONUS PHARMACEUTICALS, INC. ANNOUNCES THIRD QUARTER RESULTS |
|
|
Oct 31, 1995 |
936 |
| Molecular Biosystems appoints Bobba Venkatadri president and chief operating officer. |
|
|
Oct 18, 1995 |
369 |
| FDA Advisory Panel Defers Decision on Immunomedics' CEA-Scan for Colorectal Cancer Imaging. |
|
|
Oct 18, 1995 |
333 |
| EZ-E-EM signs agreement with Bowman Gray to develop virtual colonoscopy contrast agents. |
|
|
Aug 8, 1995 |
506 |
| MEDCO RESEARCH AND FUJISAWA USA SETTLE LAWSUITS OVER ADENOSCAN |
|
|
May 22, 1995 |
245 |
| BERLEX RECEIVES FDA MARKET CLEARANCE FOR ULTRAVIST INJECTION |
|
|
May 12, 1995 |
417 |
| WORLDWIDE CONTRAST MEDIA MARKETS TO DOUBLE BY 2000, PACED BY MRI, ULTRASOUND APPLICATIONS. |
|
|
Apr 30, 1995 |
712 |
| SCHERING AG, GERMANY TO DISCONTINUE LIPOSOME DIAGNOSTIC PROJECT |
|
|
Mar 28, 1995 |
300 |
| SONUS PHARMACEUTICALS ANNOUNCES RESULTS OF PHASE 2 CLINICAL TRIALS OF ECHOGEN(R) EMULSION |
|
|
Mar 27, 1995 |
535 |
| SONUS PHARMACEUTICALS RECEIVES PATENT FOR PROPRIETARY HIGH-Q FACTOR(TM) TECHNOLOGY |
|
|
Mar 14, 1995 |
444 |
| NYCOMED ANNOUNCES STRATEGIC DECISION TO STRENGTHEN COST STRUCTURE IN MANUFACTURING OPERATIONS |
|
|
Feb 8, 1995 |
382 |
| Interactive Medical Technologies signs agreement with Becton Dickinson. |
|
|
Nov 7, 1994 |
230 |
| BRISTOL-MYERS SQUIBB ANNOUNCES SALE |
|
|
Aug 1, 1994 |
342 |
| BRACCO, S.P.A., OF ITALY ACQUIRES DIAGNOSTICS DIVISION OF BRISTOL-MYERS SQUIBB |
|
|
Aug 1, 1994 |
698 |
| MOLECULAR BIOSYSTEMS ANNOUNCES SETTLEMENT OF SHAREHOLDER SUIT |
|
|
Apr 8, 1994 |
493 |
| METASYN, INC. COMPLETES $4 MILLION SECOND ROUND FINANCING |
|
|
Mar 21, 1994 |
340 |
| AMERICAN JOURNAL OF CARDIOLOGY REPORTS SAFETY OF OMNIPAQUE (IOHEXOL) IN CARDIAC ANGIOGRAPHY |
|
|
Oct 7, 1993 |
425 |
| MBI ANNOUNCES ALBUNEX(R) APPROVAL IN JAPAN |
|
|
Oct 4, 1993 |
450 |
| New compound aids imaging machines. |
|
|
Oct 1, 1993 |
320 |
| Indications for the use of low-osmolar contrast agents. |
Bloom, David M. |
|
Jul 1, 1989 |
709 |
| Making plastics visible to X-rays. |
Raloff, Janet |
|
Apr 22, 1989 |
187 |
|
